Erratum to: Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study

被引：0

作者：

Laura Ordoñez-Boschetti

Roberto Rey

Ana Cruz

Arijit Sinha

Tracy Reynolds

Nadina Frider

Regina Alvarenga

机构：

[1] Consultorio de Medicina Especializada del Sector Privado,

[2] Instituto Argentino de Investigación Neurológica,undefined

[3] Centro de Investigaciones Médicas Hospital Nacional Alberto Sabogal Sologuren,undefined

[4] Novartis Healthcare Pvt. Ltd.,undefined

[5] Novartis Pharma AG,undefined

[6] Novartis LAtinAmerica and Canada Region,undefined

[7] MS Hospital Da Lagoa,undefined

来源：

Advances in Therapy | 2015年 / 32卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：636 / 636

共 50 条

[41] Cardiac repolarization during fingolimod treatment in patients with relapsing-remitting multiple sclerosis [J].

Laiho, Aapo ;

Laitinen, Tiina M. ;

Hartikainen, Paivi ;

Hartikainen, Juha E. K. ;

Laitinen, Tomi P. ;

Simula, Sakari .

BRAIN AND BEHAVIOR, 2018, 8 (02)

[42] Cost-Effectiveness of Fingolimod in Treating Patients With Relapsing-Remitting Multiple Sclerosis [J].

Agashivala, Neetu V. ;

Dastani, Homa B. ;

Carlton, Rashad ;

Sarnes, Evelyn .

AMERICAN JOURNAL OF PHARMACY BENEFITS, 2011, 3 (06) :320-328

[43] Long-Term Efficacy, Safety and Tolerability of Ponesimod in Patients with Relapsing-Remitting Multiple Sclerosis [J].

Freedman, Mark ;

Boster, Aaron ;

Fernandez, Oscar ;

Melanson, Maria ;

Pozzilli, Carlo ;

D'Ambrosio, Daniele ;

Sidorenko, Tatiana ;

Olsson, Tomas .

NEUROLOGY, 2013, 80

[44] Alemtuzumab as alternative to patients with relapsing-remitting multiple sclerosis who failed to Fingolimod [J].

Lopez Real, A. M. ;

Pena Martinez, J. ;

Llaneza Gonzalez, M. ;

Solar Sanchez, D. M. ;

Garcia Estevez, D. A. ;

Gonzalez Quintanilla, V. ;

Pato Pato, A. ;

Gonzalez Suarez, I. ;

Garcia-Pelayo Rodriguez, A. M. ;

Rodriguez Regal, A. ;

Rodriguez Rodriguez, M. ;

Suarez Moro, R. ;

Arias Gomez, M. .

MULTIPLE SCLEROSIS JOURNAL, 2019, 25 :867-868

[45] Fingolimod discontinuation restores cardiovagal gain in patients with relapsing-remitting multiple sclerosis [J].

Roy, S. ;

Wang, R. ;

Liu, M. ;

Leal, C. de Rojas ;

Lee, D. -H. ;

Linker, R. A. ;

Hilz, M. J. .

EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 :533-533

[46] Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase I trial [J].

Bar-Or, Amit ;

Calabresi, Peter A. J. ;

Arnlod, Douglas ;

Markowitz, Clyde ;

Shafer, Stuart ;

Kasper, Lloyd H. ;

Waubant, Ernmanuelle ;

Gazda, Suzanne ;

Fox, Robert J. ;

Panzara, Michael ;

Sarkar, Neena ;

Agarwal, Sunil ;

Smith, Craig H. .

ANNALS OF NEUROLOGY, 2008, 63 (03) :395-400

[47] Natalizumab: safety and risk in patients with relapsing-remitting multiple sclerosis [J].

Rodriguez de Castro, Belen ;

Martinez-Mugica Barbosa, Cristina ;

Ayastuy Ruiz, Aitor ;

Fernandez Gonzalez, Beatriz .

EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2021, 28 (02) :112-114

[48] The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymeric mixture, in patients with relapsing-remitting multiple sclerosis [J].

De Stefano, N. ;

Filippi, M. ;

Confavreux, C. ;

Vermersch, P. ;

Simu, M. ;

Sindic, C. ;

Hupperts, R. ;

Bajenaru, O. ;

Edan, G. ;

Grimaldi, L. ;

Marginean, I. ;

Medaer, R. ;

Orefice, G. ;

Pascu, I. ;

Pelletier, J. ;

Sanders, E. ;

Scarpini, E. ;

Mancardi, G. L. .

MULTIPLE SCLEROSIS, 2009, 15 (02) :238-243

[49] Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study [J].

Totaro, Rocco ;

Di Carmine, Caterina ;

Costantino, Gianfranco ;

Fantozzi, Roberta ;

Bellantonio, Paolo ;

Fuiani, Aurora ;

Mundi, Ciro ;

Ruggieri, Stefano ;

Marini, Carmine ;

Carolei, Antonio .

MULTIPLE SCLEROSIS INTERNATIONAL, 2015, 2015

[50] Safety and tolerability of daclizumab HYP treatment in relapsing-remitting multiple sclerosis: results of the DECIDE study [J].

Selmaj, K. ;

Kappos, L. ;

Arnold, D. L. ;

Havrdova, E. ;

Boyko, A. ;

Kaufman, M. ;

Wiendl, H. ;

Rose, J. ;

Greenberg, S. ;

Demirhan, E. ;

Riester, K. ;

Sweetser, M. ;

Elkins, J. .

MULTIPLE SCLEROSIS JOURNAL, 2014, 20 :109-109

← 1 2 3 4 5 →